Flagship Biotech International Private Limited

Flagship Biotech International Private Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U74120MH2011PTC220700 Incorporated 09 August 2011 ROC Mumbai HQ Navi Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME
Data last updated
Revenue · FY 2025
₹117.23 Cr
▲ 22% YoY
Net profit · FY 2025
₹9.65 Cr
Net margin 8.2%
EBITDA · FY 2025
₹17.11 Cr
EBITDA margin 14.6%
Authorised capital
₹1.08 Cr
Registered with MCA
Paid-up capital
₹13.26 Lakh
Issued & subscribed
Open charges
₹59.67 Cr
Satisfied ₹8.68 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
99
Provident fund records

About Flagship Biotech International Private Limited

Data last updated:

Flagship Biotech International Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 August 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2011PTC220700. Its GSTIN is 27AABCF8053E1ZR (Maharashtra). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹1.08 Cr and a paid-up capital of ₹13.26 Lakh. It is led by directors including Shailesh Dilipbhai Patel and Tejaswini Kedar Vidwans.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Office No 1302 13th Floor Plot No A1 Sector 1 Millennium Business Park Mahape, Navi Mumbai, Maharashtra, India – 400710.

As per the financials filed for FY 2025, the company reported a revenue of ₹117.23 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹9.65 Cr (net margin 8.2%) and EBITDA of ₹17.11 Cr (EBITDA margin 14.6%). Revenue has grown at a compounded annual rate (CAGR) of 15% over five years.

The company has about 99 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.

As per MCA filings, the company has open charges of ₹59.67 Cr and satisfied charges of ₹8.68 Cr on record. Court records list 5 cases involving the company, including 4 filed by the company and 1 filed against it; 2 cases are pending. The company has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹12.2 Lakh; the latest was in March 2023. The company has 13 MSME Form 1 returns on record between 2018 and 2024, listing 268 overdue payments to 59 micro and small suppliers.

Flagship Biotech International Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-33-0014661). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website flagshipbiotech.com.

Company details

CIN U74120MH2011PTC220700
Registration Number 220700
Incorporation Date 09 August 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-33-0014661
Key People
Shailesh Dilipbhai Patel Director Tejaswini Kedar Vidwans Director Kedar Avinash Vidhwans Director

Recognitions & Rankings of Flagship Biotech International

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-MH-33-0014661

Contact details

Flagship Biotech International Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is flagshipbiotech.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    flagshipbiotech.com
  • Registered Address
    Office No 1302 13th Floor Plot No A1 Sector 1 Millennium Business Park Mahape, Navi Mumbai, Maharashtra, India – 400710
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Flagship Biotech International Private Limited, buy the company report.

Comprehensive company report
Flagship Biotech International Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Flagship Biotech International is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Flagship Biotech International Private Limited, buy the company report.

Financials of Flagship Biotech International Private Limited

FY 2024 filings available

Flagship Biotech International Private Limited reported revenue of ₹117.23 Cr (up 22% YoY) for FY 2025.

Revenue · FY 2025
₹117.23 Cr ▲ 22%
Net profit · FY 2025
₹9.65 Cr margin 8.2%
EBITDA · FY 2025
₹17.11 Cr margin 14.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 22%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▼ 10%
5 years · compounded
▲ 16%

Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 22% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹17.11 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹9.65 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin14.6%
Net Profit Margin8.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Flagship Biotech International Private Limited, buy the company report.

Board of directors of Flagship Biotech International Private Limited

Flagship Biotech International has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shailesh Dilipbhai Patel
Also directs: Flagship Ingrevia Private Limited, Flagship Biotech Foundation, Divine Laboratories Pvt. Ltd.
Director09 Aug 201115 Years 2 MonthsCurrent
Tejaswini Kedar Vidwans
Also directs: Brigid Wellness Private Limited, Flagship Biotech Foundation
Director09 Aug 201115 Years 2 MonthsCurrent
Kedar Avinash Vidhwans
Also directs: Blue Paradigm Pharmaceuticals LLP, Flagship Ingrevia Private Limited, Brigid Wellness Private Limited and 3 more
Director09 Aug 201115 Years 2 MonthsCurrent
Dipaben Shailesh Patel
Also directs: Flagship Biotech Foundation
Director09 Aug 201115 Years 2 MonthsCurrent
View all directors

Auditor

Flagship Biotech International Private Limited is audited by Parikh Shah Chotalia & Associates for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Parikh Shah Chotalia & AssociatesFY 2024118493W

Shareholding

The shareholding of Flagship Biotech International Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Flagship Biotech International Private Limited, buy the company report.

Charges & borrowings

Open charges
₹59.67 Cr
Satisfied charges
₹8.68 Cr
Breakdown by lending institutions
Others₹35.67 Cr
Axis Bank Limited₹24.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Mar 2025101076212Axis Bank Limited₹20 CrOpen
11 Nov 2024101007712Others₹10 CrOpen
11 Nov 2024101007711Others₹15 CrOpen
30 Sep 2024100984237Others₹10 CrOpen
30 Sep 2024100984232Others₹66.7 LakhOpen

To see the full charge records of Flagship Biotech International Private Limited, buy the company report.

Total charge records: 12 View all charges

Deals & funding

Flagship Biotech International Private Limited has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹12.2 Lakh; the latest was in March 2023.

Total deals
4
Funding rounds
2
Secondary share transfers
2
Disclosed funding
₹12.2 Lakh

Deals on record (4 of 4)

WhenDealAmountParties
Mar 2023Secondary share transferUndisclosedBuyer: 4 individuals
Seller: an individual
Mar 2022Secondary share transferUndisclosedBuyer: 4 individuals
Seller: an individual
Dec 2014Funding round₹2.2 LakhInvestors: an individual
Mar 2012Funding round₹10 LakhInvestors: 4 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Flagship Biotech International Private Limited has 13 MSME Form 1 returns on record between 2018 and 2024, listing 268 overdue payments to 59 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 59)

SupplierAmount dueDue sinceReported on
Vivek Polymer
Aspen Biopharma Labs Private Limited
Amrapali Foils
Cynergy Pharma
an individual supplier

To see the full MSME payment records of Flagship Biotech International Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Flagship Biotech International has 2 subsidiary companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.

2
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Flagship Ingrevia Private LimitedU24290MH2021PTC359714
Divine Laboratories Pvt. Ltd.U99999GJ1994PTC021765

To see the full group structure of Flagship Biotech International Private Limited, buy the company report.

Employees & EPFO

Flagship Biotech International Private Limited has a workforce of 99 employees on its EPFO records as of Mar 21, 2024, across 1 active EPFO establishment.

Employee count
99
Active EPFO establishments
1
Employee growth
6.45%

GST

Flagship Biotech International has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
27AABCF8053E1ZRMaharashtraActive01 Jul 2017
24AABCF8053E1ZXGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Flagship Biotech International Private Limited, buy the company report.

Recent activity

Flagship Biotech International Private Limited has 6 board changes on record since 2011: 4 appointments and 2 cessations. The latest: Jesuwin Agnal Kalampukattuserry Cherian ceased to be Director on 16 Jul 2021.

Charges
A charge with Others of Rs. 10.00 Cr registered on 11 Nov 2024 with Charge ID 101007712 was modified on 03 May 2025.
Charges
A charge with Others of Rs. 15.00 Cr registered on 11 Nov 2024 with Charge ID 101007711 was modified on 03 May 2025.
Charges
A charge with Others of Rs. 10.00 Cr registered on 30 Sep 2024 with Charge ID 100984237 was modified on 03 May 2025.
Charges
A charge with Others of Rs. 0.67 Cr registered on 30 Sep 2024 with Charge ID 100984232 was modified on 03 May 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 20.00 Cr with Charge ID 101076212 was registered on 26 Mar 2025.
Charges
A charge with Axis Bank Limited of Rs. 4.00 Cr registered on 28 Aug 2018 with Charge ID 100206588 was modified on 26 Mar 2025.
Charges
A charge registered on 31 May 2016 via Charge ID 100034850 with Others was fully satisfied on 18 Mar 2025.
Charges
A charge registered on 07 Oct 2016 via Charge ID 100058846 with Others was fully satisfied on 10 Mar 2025.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101007712 was registered on 11 Nov 2024.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101007711 was registered on 11 Nov 2024.
AGM
Flagship Biotech International Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100984237 was registered on 30 Sep 2024.

21 earlier events are in the company report.

News

Frequently asked questions

Flagship Biotech International is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 August 2011 (15+ years old) and is registered under CIN U74120MH2011PTC220700.

Flagship Biotech International has 4 current directors:

The latest financial statements of Flagship Biotech International on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Flagship Biotech International is 27AABCF8053E1ZR, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AABCF8053E1ZX (Gujarat).

The CIN (Corporate Identification Number) of Flagship Biotech International is U74120MH2011PTC220700. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Flagship Biotech International has 5 court cases on record: 4 filed by the company and 1 filed against it. 2 are pending. Most are in the district courts.

Flagship Biotech International was incorporated on 09 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.

Flagship Biotech International has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹12.2 Lakh; the latest was in March 2023.

Jesuwin Agnal Kalampukattuserry Cherian ceased to be Director on 16 Jul 2021. Prema Jesuwin Cherian ceased to be Director on 16 Jul 2021. Dipaben Shailesh Patel was appointed as Director on 09 Aug 2011. Flagship Biotech International has 6 board changes on record in total.

Yes, Flagship Biotech International is registered as an MSME under Udyam registration (number: UDYAM-MH-33-0014661).

Flagship Biotech International has 13 MSME Form 1 returns on record between 2018 and 2024, listing 268 overdue payments to 59 micro and small suppliers. The latest return was filed on 03 May 2024.